MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Dopamine dysfunction in nigro-striatal pathway—multi-axial pathology in SCA 12

    P. Basu, J. Ganguly, S. Pandey, S. Mukherjee, N. Singh, S. Choudhury, H. Kumar (Kolkata, India)

    Objective: To assert pathophysiology in spinocerebellar ataxia type 12 (SCA12) extends way beyond cerebellar or spinal pathology. To further sensitise scientific community about consistent nigro-striatal…
  • 2023 International Congress

    Identification of a Metabolic Brain Pattern Specific to Corticobasal Degeneration and Its Utility in Differential Diagnosis

    T. Rus, J. Jamšek, M. Perovnik, M. Trošt (Ljubljana, Slovenia)

    Objective: To identify a metabolic brain pattern specific to corticobasal degeneration (CBD) and to develop a machine learning algorithm that can differentiate CBD from other…
  • 2023 International Congress

    New machine learning approaches in tic detection: Seeking to learn more about the characteristic of tics

    L. Becker, R. Schappert, N. Brügge, G. Sallandt, F. Li, J. Friedrich, T. Bäumer, C. Frings, C. Beste, R. Stenger, V. Roessner, H. Handels, S. Fudickar, A. Münchau (Lübeck, Germany)

    Objective: To develop a machine learning tool to distinguish between facial/head tics in people with Tourette syndrome and spontaneous movements in healthy controls. Background: Distinguishing…
  • 2023 International Congress

    Chorea following SARS-CoV-2 infection and vaccination: a systematic review

    R. Bilavu, M. Simu, E. Rosca (Timișoara, Romania)

    Objective: We aimed to investigate and compare data on chorea following SARS-CoV-2 infection and vaccination to provide an extensive perspective on this pathology and to…
  • 2023 International Congress

    Minimum clinically important difference (MCID) on the Unified Wilson Disease Rating Scale (UWDRS) Part III: results from the Phase 3 FoCus Trial

    T. Litwin, A. Czlonkowska, P. Hedera, J. Bronstein, M. Lorincz, M. Møller, G. Wegmann, G. Carron, A. Messali, A. Poujois (Warsaw, Poland)

    Objective: Minimum clinically important differences (MCID) on the Unified Wilson Disease Rating Scale (UWDRS) Part III were estimated using data from a phase III trial…
  • 2023 International Congress

    Development of a health-related quality-of-life (HR-QoL) questionnaire for hereditary spastic paraplegia (HSP) patients and caregivers.

    J. Malina, E-M. Hüßler, B. Schröder, N. Wiesenberg, T. Kühl, S. Klebe (Essen, Germany)

    Objective: The aim of this project is to develop and validate a health-related quality-of-life (HR-QoL) questionnaire, in a patient and a caregiver version, specific for…
  • 2023 International Congress

    Factors influencing health-related quality of life of patients with spinocerebellar ataxia

    N. Weber, M. Buchholz, A. Rädke, J. Faber, T. Schmitz-Hübsch, H. Jacobi, T. Klockgether, B. Michalowsky (Greifswald, Germany)

    Objective: The objective was to demonstrate the progression of HRQoL over time and identify factors affecting SCA patients' HRQoL. Background: Spinocerebellar ataxias (SCA) comprise a…
  • 2023 International Congress

    Computerized cognitive training in advanced Parkinson’s disease: preliminary feasibility data of an ongoing randomized controlled trial

    P. Olgemöller, E. Kalbe, C. Hennen, M. Barbe, M. Hellmich, AK. Folkerts (Cologne, Germany)

    Objective: To analyse the feasibility and effects on cognitive- and non-cognitive outcomes, and prediction of responsiveness of a computerized cognitive training (CT) in comparison to…
  • 2023 International Congress

    Artificial intelligence for the improvement of imaging biomarkers in Parkinson’s disease

    V. Dzialas, E. Doering, K. Simonyan, A. Strafella, D. Vaillancourt, T. van Eimeren (Cologne, Germany)

    Objective: To systematically review the current literature on the application of artificial intelligence (AI) for imaging biomarkers in Parkinson's disease (PD) and to identify translational…
  • 2023 International Congress

    Text entry as a digital outcome in Parkinson’s disease patients (TEXT-PD): results from two exploratory studies

    L. Azevedo Kauppila, A. Rodrigues, F. Pona Ferreira, M. Leitão, A. Santos, D. Branco, H. Nicolau, J. Ferreira, T. Guerreiro (Torres Vedras, Portugal)

    Objective: To evaluate the feasibility and psychometric properties of text entry (TE) and touch metrics as digital outcomes for PD patients. Background: TE on smartphones…
  • « Previous Page
  • 1
  • …
  • 418
  • 419
  • 420
  • 421
  • 422
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley